Predicting Treatment Response to 1st-line Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with High PDL1 Expression

JOURNAL OF THORACIC ONCOLOGY(2021)

引用 0|浏览4
暂无评分
关键词
immunotherapy, CT, radiomics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要